Search for Clinical Trial Results

Pulmonary Alveolar Proteinosis - 18 Studies Found
Status | Study |
Recruiting |
Study Name: Inhalation of Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Autoimmune Pulmonary Alveolar Proteinosis (PAP) Condition: Autoimmune Pulmonary Alveolar Proteinosis Date: 2014-09-14 Interventions: Drug: GM-CSF Other Name: HUABEI JIMUXIN |
Not yet recruiting |
Study Name: Evaluation of a Single Dose of Inhaled Sargramostim in Patients With Autoimmune Pulmonary Alveolar Proteinosis Condition: Autoimmune Pulmonary Alveolar Proteinosis Date: 2016-11-28 Interventions: Drug: Sargramostim Other Names:
|
Recruiting |
Study Name: Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Condition: Autoimmune Pulmonary Alveolar Proteinosis Date: 2016-02-28 Interventions:
|
Recruiting |
Study Name: Whole Lung Lavage (WLL)/Inhaled Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis (PAP) Condition: Pulmonary Alveolar Proteinosis Date: 2009-05-11 Interventions:
|
Recruiting |
Study Name: A National Registry For Pulmonary Alveolar Proteinosis Condition: Pulmonary Alveolar Proteinosis Date: 2015-05-28 |
Completed |
Study Name: Multicenter International Cross-Sectional Evaluation of Pulmonary Alveolar Proteinosis Trial Condition: Pulmonary Alveolar Proteinosis Date: 2016-11-28 Interventions: Other: Retrospective Chart Review No intervention. |
Completed |
Study Name: Inhaled Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in Hereditary Pulmonary Alveolar Proteinosis (PAP) Condition: Hereditary Pulmonary Alveolar Proteinosis Date: 2011-12-12 Interventions: Drug: Leukine Participants will receive inhaled rhGM-CSF (Sargramostim, Leukine) at the dose of 250 mcg |
Terminated |
Study Name: GM-CSF in Patients With Pulmonary Alveolar Proteinosis Condition: Pulmonary Alveolar Proteinosis Date: 2002-01-30 Interventions: Drug: GM-CSF (granulocyte-macrophage colony-stimulating factor, sargramostim) |
Active, not recruiting |
Study Name: Pulmonary Alveolar Proteinosis GM-CSF Inhalation Efficacy Trial in Japan Condition: Pulmonary Alveolar Proteinosis, Autoimmune Date: 2016-07-13 Interventions:
|
Recruiting |
Study Name: Prospective Trial of Rituximab for Primary Pulmonary Alveolar Proteinosis Condition:
Date: 2007-10-31 Interventions: Drug: rituximab IV, 1000 mg, two weeks, 2 times Othe |